Athira Pharma, INC. (LONA) — 8-K Filings

8-K Filings (11)

• Athira Pharma Files 8-K Report — Oct 3, 2025 Risk: medium
  On October 2, 2025, Athira Pharma, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific details regardin
• Athira Pharma Files 8-K on Security Holder Rights — Sep 11, 2025 Risk: medium
  Athira Pharma, Inc. filed an 8-K on September 10, 2025, reporting material modifications to the rights of security holders and amendments to its articles of inc
• Athira Pharma Files 8-K on Shareholder Votes — Jun 2, 2025 Risk: low
  Athira Pharma, Inc. filed an 8-K on May 29, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details
• Athira Pharma Faces Delisting Concerns — Apr 16, 2025 Risk: high
  Athira Pharma, Inc. has filed an 8-K report on April 15, 2025, indicating a notice of delisting or failure to satisfy a continued listing rule or standard. The
• Athira Pharma Faces Nasdaq Delisting Warning — Oct 18, 2024 Risk: high
  Athira Pharma, Inc. announced on October 16, 2024, that it received a notice from The Nasdaq Stock Market indicating a failure to meet the minimum bid price req
• Athira Pharma Announces Board, Executive Changes & Compensation — Oct 7, 2024 Risk: medium
  Athira Pharma, Inc. announced on October 1, 2024, changes in its board of directors and executive compensation. Dr. Hans-Ulrich Siehl has been appointed as a ne
• Athira Pharma CMO Departs, Interim Appointed — Sep 17, 2024 Risk: medium
  Athira Pharma, Inc. announced on September 15, 2024, the departure of its Chief Medical Officer, Dr. T. David Smith, and the appointment of Dr. Hans-Ulrich Demu
• Athira Pharma Files 8-K Report — Sep 3, 2024 Risk: low
  On September 3, 2024, Athira Pharma, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements a
• Athira Pharma Files 8-K on Shareholder Votes & Financials — May 29, 2024 Risk: low
  Athira Pharma, Inc. filed an 8-K on May 23, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing details the
• Athira Pharma Files 8-K — May 17, 2024 Risk: low
  Athira Pharma, Inc. filed an 8-K on May 17, 2024, reporting an event that occurred on May 3, 2024. The filing pertains to financial statements and exhibits, ind
• Athira Pharma 8-K: Operations, Officer Changes Reported Jan 4 — Jan 8, 2024
  Athira Pharma, Inc. filed an 8-K on January 8, 2024, reporting events that occurred on January 4, 2024. This filing indicates that the company is updating its p

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX